Advertisement
Absci Corporation (ABSI)
NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Follow
At close: 04:00PM EST
After hours:
| Previous Close | 2.8300 |
| Open | 2.8200 |
| Bid | 2.7100 x 200 |
| Ask | 2.8000 x 200 |
| Day's Range | 2.7400 - 2.8400 |
| 52 Week Range | 1.3500 - 6.7200 |
| Volume | |
| Avg. Volume | 1,040,793 |
| Market Cap | 315.854M |
| Beta (5Y Monthly) | 2.19 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -0.9300 |
| Earnings Date | Nov 12, 2024 |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | 8.29 |
GlobeNewswireAbsci to Participate in the 36th Annual Piper Sandler Healthcare Conference
VANCOUVER, Wash. and NEW YORK, Nov. 21, 2024 (GLOBE NEWSWIRE) -- Absci Corporation (Nasdaq: ABSI), a data-first generative AI drug creation company, today announced the company will be participating in the upcoming 36th Annual Piper Sandler Healthcare Conference in New York, NY. Absci’s Founder & CEO Sean McClain is scheduled to participate in a panel discussion titled “The Promise of AI in Drug Development” on Thursday, December 5th at 2:00 p.m. Eastern Time. Interested parties may contact thei
- GuruFocus.com
Absci Corp (ABSI) Q3 2024 Earnings Call Highlights: Strategic Partnerships and Financial Challenges
Absci Corp (ABSI) showcases promising collaborations and a robust pipeline amid rising R&D expenses and revenue challenges.
Advertisement
Advertisement
Advertisement
© 2024 Yahoo. All rights reserved.